Study of Mocetinostat in Selected Patients With Mutations of Acetyltransferase Genes in Relapsed and Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
Clinical trial NCT02282358 · TERMINATED
Trial details
- NCT number
- NCT02282358
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2023-05-26
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.